Functional lineage tracing to study the clonal evolution of therapy resistance
1Cancer Cell Signaling, Boehringer-Ingelheim RCV GmbH & Co KG, Vienna, Austria. Christian.Umkehrer@Boehringer-Ingelheim.com.
Nature Reviews. Cancer
|April 23, 2022
Summary
No abstract available in PubMed .
Related Concept Videos
Lineage Commitment
3.3K
Commitment is the process whereby stem cells:
3.3K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
T Cell Activation and Clonal Selection
6.3K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
6.3K


